Mont-Saint-Guibert, Belgium – Celyad Oncology SA (Euronext & Nasdaq: CYAD), a clinical-stage biotechnology company focused on the discovery and development of chimeric antigen receptor T cell (CAR T) therapies for cancer, today announced that the company plans to participate at the following conferences in September 2020:
Wells Fargo 2020 Virtual Healthcare Conference
| Date: | Wednesday, September 9, 2020 |
| Time: | 9:20 a.m. EDT |
| Webcast: | A live and archived webcast of the presentation will be available in the Events section of the Celyad Oncology website |
Knowledge for Growth 2020
| Date: | September 9 – September 10, 2020 |
H.C. Wainwright 22nd Annual Global Investment Conference
| Date: | Monday, September 14, 2020 |
| Time: | 3:30 p.m. EDT |
| Webcast: | A live and archived webcast of the presentation will be available in the Events section of the Celyad Oncology website |
